Acorda Therapeutics
ACOR
#10342
Rank
NZ$1.37 M
Marketcap
$1.11
Share price
0.00%
Change (1 day)
-95.65%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -$17.60

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -$16.42. In 2022 the company made an earnings per share (EPS) of -$148.13 an increase over its 2021 EPS that were of -$335.23.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.60-88.12%
2022-$148.13-55.81%
2021-$335.23-16.13%
2020-$399.72-65.51%
2019-$1,159-898.61%
2018$145.11-114.88%
2017-$975.45536.84%
2016-$153.17-392.31%
2015$52.40-39.53%
2014$86.664.88%
2013$82.63-89.54%
2012$790.04409.09%
2011$155.19-333.33%
2010-$66.51-85.14%
2009-$447.421.37%
2008-$441.3751.03%
2007-$292.23-68.27%
2006-$921.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.51-121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.31-107.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.33-91.92%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-$13.15-19.92%๐Ÿ‡บ๐Ÿ‡ธ USA